BTNL2 gene

Last updated on: 31.03.2024

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

The BTNL2 gene (BTNL2 stands for butyrophilin like 2) is a protein-coding gene located on chromosome 6p21.32. The BTNL2 gene encodes a major histocompatibility complex class II associated type I transmembrane protein that belongs to the butyrophilin-like B7 family of immunoregulators . This protein is thought to be involved in immunosurveillance. It functions as a "negative T cell regulator" by decreasing T cell proliferation and cytokine release.

General informationThis section has been translated automatically.

The encoded protein contains an N-terminal signal peptide, two pairs of immunoglobulin-like domains separated by a heptad peptide sequence, and a C-terminal transmembrane domain.

Naturally occurring mutations in this gene are associated with sarcoidosis, rheumatoid arthritis, myositis, type 1 diabetes, systemic lupus erythematosus, roazea (Awosika O et al. (2018), acute coronary syndrome and prostate cancer (Lin Y et al. 2015; Du Y et al. 2022).

Ulcerative colitis, inflammatory bowel disease: A rare coding variant p.G454C in the BTNL2 gene within the major histocompatibility complex was significantly associated with an increased risk of IBD (p = 9.65x10-10, OR = 2.3[95% CI = 1.75-3.04]). This finding is independent of the known common associated CD and UC variants at this locus (Prescott NJ et al. 2015).

LiteratureThis section has been translated automatically.

  1. Awosika O et al. (2018) Genetic Predisposition to Rosacea. Dermatol Clin 36):87-92
  2. Du Y et al. (2022) Cancer cell-expressed BTNL2 facilitates tumor immune escape via engagement with IL-17A-producing γδ T cells. Nat Commun 13:231.
  3. Lin Y et al. (2015) BTNL2 gene polymorphism and sarcoidosis susceptibility: a meta-analysis. PLoS One 10:e0122639.
  4. Milman N et al. (2011) The BTNL2 A allele variant is frequent in Danish patients with sarcoidosis. Clin Respir J 5:105-111.
  5. Ozdemir M et al. (2014) Is there a genetic predisposition for Turkish patients with sarcoidosis in the 329-bp region containing the BTNL2 rs2076530 polymorphism? Turk J Med Sci 44:590-594.
  6. Prescott NJ et al. (2015) Pooled sequencing of 531 genes in inflammatory bowel disease identifies an associated rare variant in BTNL2 and implicates other immune related genes. PLoS Genet 11:e1004955.

Last updated on: 31.03.2024